Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 26726501000001119 | BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 42365401000001119 | BiCNU 100mg powder and solvent for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 10 vial | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Is a | Carmustine 100mg powder and solvent for solution for injection vials 10 vial | true | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Is pack of | BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) | false | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available | true | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Has active ingredient | Carmustine | false | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Discontinued indicator | Never discontinued | false | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Has AMP | BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) | true | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Has specific active ingredient | Carmustine | true | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Has dispensed dose form | Powder and solvent for solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | VMP non-availability indicator | Not available | false | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Discontinued indicator | Discontinued AMPP(qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | VMP non-availability indicator | Re-introduced | true | Inferred relationship | Existential restriction modifier | ||
| BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial | Has dispensed dose form | Powder and solvent for solution for infusion | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR